New oral migraine drug called Amerge
March 1998
You'll see a new oral migraine drug called Amerge. Glaxo is introducing it now in the U.S....a little later in Canada.
Amerge (naratriptan) is similar to Imitrex (sumatriptan)...except Amerge is longer-acting.
This means fewer recurrent headaches with Amerge than with Imitrex. About 40% of patients using Imitrex have recurrent headaches because of its short half-life.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive